Richard Ettl interviewed by TechCrunch
SkyCell has successfully closed the recent round of Series C funding with $35M. This enables SkyCell to further improve the experience we offer our clients, further differentiate our hardware and SaaS offerings and to become the distribution solution of choice for cold chain.
We were pleased to see our Series C funding round covered by TechCrunch this week. Our CEO and Co-Founder, Richard Ettl, spoke to reporter Emma Betuel about the particulars of the investors and expanded on issues related to the biopharma industry itself.
From highlighting SkyCell’s annually audited excursion rate of less than 0.1% compared to the industry standard, to discussing macro trends within the industry and the company’s expanding partnerships, Emma and Richard tackled many topics of interest.
Read the full article here.
News & Stories
SkyCell Launches Net ZERO Reverse: Transforming Sustainable Pharma Supply Chain
SkyCell has introduced Net ZERO Reverse, a groundbreaking service designed to revolutionize pharmaceutical supply chains by significantly reducing carbon emissions....
Redefining The Total Cost of Ownership Formula
The Total Cost of Ownership (TCO) is a vital metric for evaluating the full cost of a product throughout its...
Using Technology to Drive Sustainability and Visibility
Sustainability and visibility are two of the most pressing challenges for the modern pharma supply chain. Rising regulations and carbon...